Klein Lawrence Otto is a director of Jasper Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
3
Oruka Therapeutics, Inc.
6 Sep 24
4
Jasper Therapeutics, Inc.
8 Jun 23
4
Jasper Therapeutics, Inc.
13 Oct 22
4
CRISPR Therapeutics AG
18 Aug 22
4
Dyne Therapeutics, Inc.
6 Jul 22
4
Dyne Therapeutics, Inc.
6 Jun 22
4
Jasper Therapeutics, Inc.
23 Mar 22
4
CRISPR Therapeutics AG
14 Mar 22
4
CRISPR Therapeutics AG
22 Feb 22
4
CRISPR Therapeutics AG
7 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jun 23 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 1.6 | 47,000 | 75.20 k | 47,000 |